*Takumi Nakamura¹, Takashi Tsuboi², Tadafumi Kato³, Atsushi Takata¹ (1. RIKEN Center for Brain Science, 2. Graduate School of Arts and Sciences, The University of Tokyo, 3. Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine)

*Yuri Kim¹, Takahiro Goto¹, Takaki Watanabe², Shuhei Fujino², Yuki Sugaya², Masanobu Kano^2,3, Daichi Kawaguchi¹, Yukiko Gotoh^1,3 (1. Graduate School of Pharmaceutical Sciences, The University of Tokyo, 2. Graduate School of Medicine, The University of Tokyo, 3. International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo)

*Yoki Tatsumi¹, Kaori Emoto¹, Daichi Kawaguchi¹, Yukiko Gotoh¹ (1. Grad Sch Pharm, Univ of Tokyo, Tokyo, Japan)

*Seico Benner^1,2, Toshihiro Endo³, Hidenori Yamasue² (1. Health Env Risk, NIES, Tsukuba, Japan, 2. Dep Psychiatry, Hamamatsu Uni Sch Med, Hamamatsu, Japan, 3. Phenovance, LLC, Kashiwa, Japan)